在癌症中准TEAD
Rohith Battina1, Raneen Rahhal1, Anton Wellstein1
1Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington D.C., United States.
Frontiers in oncology
|December 5, 2025
概括
针对TEAD-YAP/TAZ复合体是一种有前途的癌症治疗方法. 干扰这种相互作用的抑制剂正在临床试验中,为治疗各种癌症提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 河马通路在癌症中经常失调,促进瘤生长.
- 转录因子TEAD,结合YAP/TAZ联合激活剂,对细胞增殖至关重要,并与癌症预后不佳有关.
研究的目的:
- 在瘤学中审查针对TEAD与YAP/TAZ相互作用的治疗潜力.
- 讨论用于癌症治疗的YAP/TAZ-TEAD复合物的结构,功能和抑制.
主要方法:
- 关于河马通路,TEAD,YAP/TAZ和癌症的现有文献的审查.
- 分析TEAD-YAP/TAZ复合体的蛋白质-蛋白质相互作用和结构数据.
- 检查针对YAP/TAZ-TEAD复合体的药理学药剂及其临床试验状态.
主要成果:
- TEAD-YAP/TAZ相互作用对于致癌基因转录至关重要.
- 已经开发了几种针对YAP/TAZ-TEAD综合体的毒剂.
- TEAD 抑制剂正在进行各种癌症类型的临床试验.
结论:
- 针对TEAD-YAP/TAZ相互作用是瘤学中可行的治疗策略.
- 了解YAP/TAZ-TEAD复合体可以为开发新型抗癌药物提供信息.
- 临床试验正在评估TEAD抑制剂在癌症患者中的有效性和安全性.
关键词:
在TAZ (Hippo) 信号中使用TAZ信号.泰德家族 (Tead Family) 是一个家庭.有 TEAD 抑制剂的患者.在YAP (Hippo) 信号系统中.在YAP/TAZ TEAD信号传输中.更多相关视频
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.5K
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
6.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
